<DOC>
	<DOCNO>NCT00097708</DOCNO>
	<brief_summary>The purpose study determine whether experimental anti-anxiety medication effective treatment Generalized Anxiety Disorder .</brief_summary>
	<brief_title>Experimental Medication For Treatment Generalized Anxiety Disorder</brief_title>
	<detailed_description>Protocol 04-001-01 The primary objective study ass , control condition , safety efficacy experimental anti-anxiety medication relative placebo subject generalize anxiety disorder ( GAD ) . The secondary objective study study algorithms discontinuation experimental anti-anxiety medication . Recruiting : Participants currently recruit enrol .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Anti-Anxiety Agents</mesh_term>
	<criteria>Subjects 18 65 year age eligible participate satisfy DSMIVTR criterion diagnosis GAD . No primary psychiatric diagnosis besides GAD .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Double Blind , Placebo control , Safety Efficacy</keyword>
	<keyword>Generalized Anxiety Disorder</keyword>
</DOC>